Abstract:Background and aimsAn extract of the seed from celery (Apium graviolens) (CSE), and fractions thereof, have been found to possess anti-inflammatory activity, gastro-protective activity, and anti-Helicobacter pylori activity. In view of the potential for employing these extracts for therapeutic use, toxicological investigations were undertaken with an alcoholic extract (A-CSE) which has previously been shown to have the above pharmacological activities.MethodsA 28-day toxicity study was performed in rats according to Good Laboratory Practice (GLP) conditions. Eighteen adult male and 18 adult female rats were randomly assigned to 3 treatment groups of 6 rats/sex/group and were dosed orally with A-CSE of 0, 150 or 5,000 mg/kg per day. Daily observations of vital signs and body weights were recorded and ophthalmological investigations were performed. At autopsy, the principal organs were weighed and sections collected for histological analysis. Serum and urine samples were collected at termination for routine clinical chemistry. Under non-GLP conditions alpha-2-μ-globulin immunohistochemistry was performed on kidney tissues and hepatic cytochrome P450 protein was determined, as well as, the enzymatic activities of the principal isoforms.ResultsAll animals survived treatments with no visible or behavioral signs of toxicity being observed during the study. There were no statistically significant differences in body weight gains, body weight gains per day or cumulative absolute body weight gains, for either sex, in any treatment groups when compared with controls. Slightly increased liver weight and liver to body and brain weight ratios were observed in female rats and in liver to body weight ratios in male rats given high dose A-CSE which was a test article effect, but the absence of any microscopic correlates for the liver weight increases suggests that these were not toxicologically significant. Treatment related macroscopic changes were not observed at necropsy and microscopic findings were limited to minimal increases in gastric eosinophils in several male and female rats in the 5,000 mg/kg per day treatment groups. Minimal focal degeneration of renal tubules was observed sporadically in both sexes assigned to all treatment groups including control and was consistent with early spontaneous nephropathy of laboratory rats and thus was not considered to represent a pathologic change associated with the test article. Increased serum globulin and phosphorus levels were observed in male rats given 5,000 mg/kg per day A-CSE and decreased serum triglycerides levels in female animals given 150 or 5,000 mg/kg per day A-CSE. The increase in serum globulin and phosphorus in male animals was small in magnitude and not considered toxicologically significant. The mechanism for the decrease in serum triglycerides in female rats was not apparent. Changes in urinalysis parameters were limited to small decreases in urine pH in female animals in the 150 and 5,000 mg/kg per day groups and were not deemed toxicologically significant. Alpha-2-μ-globulin immunohistochemistry was performed on kidney tissues from all animals and found to be within normal physiologic limits. Minor corneal mineralization occurred in some animals from all treatment groups. Cataracts were observed in one in the control and one in an animal that had 5,000 mg/kg per day but since the cataracts occurred in the metabolically inactive region of the lens, these were not considered indicative of test article related lesions. There were no changes in total hepatic microsomal protein or in total cytochrome P450 protein. Although male rats appeared to have to higher levels of total microsomal protein than female rats, there appeared to be no treatment effect in either male or female animals. As regards the activity of the various isoforms tested (CYP2B1/2, CYP1A1/2, CYP3A1/2), with the large range of activities detected for each P450 isoform, no clear change in activity or protein were observed, however, these data were not statistically analyzed.ConclusionsThese results suggest that there are no toxicologically significant sub-chronic effects of oral A-CSE in rats. The no adverse effect level for systemic toxicity would appear to be 5,000 mg/kg per day.

A Two-Year Dietary Carcinogenicity Study of Cyadox in Sprague-Dawley Rats

A Chronic Toxicity Study of Cyadox in Wistar Rats.

Subchronic Oral Toxicity Study With Cyadox In Wistar Rats

Two generation reproduction and teratogenicity studies of feeding cyadox in Wistar rats.

Assessment of Thirteen-Week Subchronic Oral Toxicity of Cyadox in Beagle Dogs.

Dietary Exposure Assessment Of Cyadox Based On Tissue Depletion Of Cyadox And Its Major Metabolites In Pigs, Chickens, And Carp

Impact of Cyadox on Human Colonic Microflora in Chemostat Models

Evaluation of the Safety of Primary Metabolites of Cyadox: Acute and Sub-Chronic Toxicology Studies and Genotoxicity Assessment

The Elimination of Cyadox and Its Two Major Metabolites in Rats

Study of transport, tissue distribution, depletion, and hepatotoxicity of Cyadox, a quinoxaline-1,4-dioxide derivative

Pharmacokinetics of Cyadox and Its Main Metabolites in Rats, Pigs, Chickens, and Carps Following Oral Administration at Three Dosage.

Experimental Evaluation of Cyadox Phototoxicity to Balb/c Mouse Skin.

Metabolic Influence of Acute Cyadox Exposure on Kunming Mice

Metabolic Disposition and Elimination of Cyadox in Pigs, Chickens, Carp, and Rats

The Elimination of Cyadox and Its Two Major Metabolites in Chickens

N-O reduction and ROS-mediated AKT/FOXO1 and AKT/P53 pathways were involved in growth promotion and cytotoxicity of Cyadox.

Metabolism and Tissue Depletion of Carbadox in Swine, Broilers, and Rats

Disposition of cyadox in domesticated cats following oral, intramuscular, and intravenous administration.

A subchronic oral toxicity study on pyrroloquinoline quinone (PQQ) disodium salt in rats

Metabolism of cyadox by the intestinal mucosa microsomes and gut flora of swine, and identification of metabolites by high-performance liquid chromatography combined with ion trap/time-of-flight mass spectrometry.

A toxicological investigation of a celery seed extract having anti-inflammatory activity